• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login
Search
Generic filters

Takeda Canada Inc.

Member Profile

Takeda Canada was established April 1, 2009 as part of a significant global expansion by Takeda Pharmaceutical Company Limited, a research-based global pharmaceutical company with a 250-year heritage. Takeda is the largest pharmaceutical company in Japan and one of the top 20 pharmaceutical companies worldwide. Takeda Canada’s goal is to bring important medicines to Canadians who need them.

Sector
Biotechnology, Global Pharmaceutical Corporations, Therapeutics
Area of Expertise
  • Bioinformatics
  • Bioprocessing
  • Bioproducts
  • Cellular Medicine
  • Distributor
  • Drug Delivery
  • Drug Discovery
  • Neurophysiology
  • Oncology
  • Product Development
Company Stage Commercial Stage, Public Company
Stock Ticker 4502 - TYO

Member Profile

Biotechnology, Global Pharmaceutical Corporations, Therapeutics

Takeda Canada Inc.

Bronze Sponsor

  • Website www.takedacanada.com
  • Phone +1 (866) 397 4473
  • Email info@takedacanada.com
  • Address
    Bay Adelaide Centre, 22 Adelaide St W Suite 3800
    Toronto, ON
    M5H 4E3
  • Leadership Contact
    Matt Lee, Director, Market Access
    Follow us:
  • Twitter
  • Facebook
  • LinkedIn
  • News
  • Jobs

June 27, 2022

Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine

June 9, 2022

Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial

April 26, 2022

Takeda Recognized as 2022 ISPE Facility of the Year Awards Winner in Two Categories

April 18, 2022

Takeda’s TAKHZYRO® (lanadelumab-flyo) Prefilled Syringe Now Available for People With Hereditary Angioedema (HAE) Ages 12 Years and Older in the United States

April 12, 2022

Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fibrotic Therapies in Inflammatory Bowel Disease

No current content.

  • Twitter
  • Linkedin
Tweets by Takeda Canada Inc.
Connect with us LinkedIn

© 2022 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us